These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 18798304)

  • 21. [Treatment of metastasized malignant melanoma].
    Kamanabrou D
    Praxis (Bern 1994); 2001 Mar; 90(10):391-6. PubMed ID: 11305184
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A phase II study of biochemotherapy for the treatment of metastatic malignant melanoma.
    Gibbs P; Iannucci A; Becker M; Allen J; O'Driscoll M; McDowell K; Williams P; Rosse P; Murphy J; Gonzalez R
    Melanoma Res; 2000 Apr; 10(2):171-9. PubMed ID: 10803718
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic factors in metastatic melanoma patients treated with biochemotherapy and maintenance immunotherapy.
    Minor DR; Moore D; Kim C; Kashani-Sabet M; Venna SS; Wang W; Boasberg P; O'Day S
    Oncologist; 2009 Oct; 14(10):995-1002. PubMed ID: 19776094
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A randomized phase III study comparing dacarbazine, BCNU, cisplatin and tamoxifen with dacarbazine and interferon in advanced melanoma.
    Middleton MR; Lorigan P; Owen J; Ashcroft L; Lee SM; Harper P; Thatcher N
    Br J Cancer; 2000 Mar; 82(6):1158-62. PubMed ID: 10735499
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combination of chemotherapy with interleukin-2 and interferon-alfa for the treatment of advanced melanoma.
    Buzaid AC; Legha SS
    Semin Oncol; 1994 Dec; 21(6 Suppl 14):23-8. PubMed ID: 7992096
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Head and neck mucosal melanoma: a 32-year review.
    Loree TR; Mullins AP; Spellman J; North JH; Hicks WL
    Ear Nose Throat J; 1999 May; 78(5):372-5. PubMed ID: 10355199
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interleukin-2-based biochemotherapy for patients with stage IV melanoma: long-term survivors outside a clinical trial setting.
    Hess V; Herrmann R; Veelken H; Schwabe M
    Oncology; 2007; 73(1-2):33-40. PubMed ID: 18332650
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Liver metastases from uveal melanoma: clinical experience of hepatic arterial infusion of cisplatin, vinblastine and dacarbazine.
    Melichar B; Voboril Z; Lojík M; Krajina A
    Hepatogastroenterology; 2009; 56(93):1157-62. PubMed ID: 19760961
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Advantages of concurrent biochemotherapy modified by decrescendo interleukin-2, granulocyte colony-stimulating factor, and tamoxifen for patients with metastatic melanoma.
    O'Day SJ; Gammon G; Boasberg PD; Martin MA; Kristedja TS; Guo M; Stern S; Edwards S; Fournier P; Weisberg M; Cannon M; Fawzy NW; Johnson TD; Essner R; Foshag LJ; Morton DL
    J Clin Oncol; 1999 Sep; 17(9):2752-61. PubMed ID: 10561350
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biochemotherapy for melanoma: rational therapeutics in the search for weapons of melanoma destruction.
    Margolin KA
    Cancer; 2004 Aug; 101(3):435-8. PubMed ID: 15274056
    [No Abstract]   [Full Text] [Related]  

  • 31. Comparison of S100 protein and MIA protein as serum marker for malignant melanoma.
    Djukanovic D; Hofmann U; Sucker A; Rittgen W; Schadendorf D
    Anticancer Res; 2000; 20(3B):2203-7. PubMed ID: 10928178
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Complete remission of brain metastases in three patients with stage IV melanoma treated with BOLD and G-CSF.
    Bottoni U; Bonaccorsi P; Devirgiliis V; Panasiti V; Borroni RG; Trasimeni G; Clerico R; Calvieri S
    Jpn J Clin Oncol; 2005 Sep; 35(9):507-13. PubMed ID: 16120623
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Subcutaneous interleukin-2 and interferon-alpha plus cisplatin with and without prophylactic cimetidine in patients with metastatic malignant melanoma: a phase II study.
    Schmidt H; Geertsen PF; Fode K; Rytter C; Bastholt L; von der Maase H
    Melanoma Res; 2000 Feb; 10(1):66-77. PubMed ID: 10711642
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of postoperative adjuvant radiation therapy in the treatment of mucosal melanomas of the head and neck region.
    Owens JM; Roberts DB; Myers JN
    Arch Otolaryngol Head Neck Surg; 2003 Aug; 129(8):864-8. PubMed ID: 12925346
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systemic chemotherapy with cisplatin plus 5-FU (PF) for recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN): efficacy and safety of a lower dose of PF (80/800) at a single institution in Japan.
    Kiyota N; Tahara M; Kadowaki S; Fuse N; Doi T; Minami H; Ohtsu A
    Jpn J Clin Oncol; 2009 Apr; 39(4):225-30. PubMed ID: 19211574
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biochemotherapy in patients with metastatic anorectal mucosal melanoma.
    Kim KB; Sanguino AM; Hodges C; Papadopoulos NE; Eton O; Camacho LH; Broemeling LD; Johnson MM; Ballo MT; Ross MI; Gershenwald JE; Lee JE; Mansfield PF; Prieto VG; Bedikian AY
    Cancer; 2004 Apr; 100(7):1478-83. PubMed ID: 15042682
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Head and neck mucosal melanoma: experience with 42 patients, with emphasis on the role of postoperative radiotherapy.
    Meleti M; Leemans CR; de Bree R; Vescovi P; Sesenna E; van der Waal I
    Head Neck; 2008 Dec; 30(12):1543-51. PubMed ID: 18704960
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bcl-2 antisense (oblimersen sodium) plus dacarbazine in patients with advanced melanoma: the Oblimersen Melanoma Study Group.
    Bedikian AY; Millward M; Pehamberger H; Conry R; Gore M; Trefzer U; Pavlick AC; DeConti R; Hersh EM; Hersey P; Kirkwood JM; Haluska FG;
    J Clin Oncol; 2006 Oct; 24(29):4738-45. PubMed ID: 16966688
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical results using biochemotherapy as a standard of care in advanced melanoma.
    Chapman PB; Panageas KS; Williams L; Wolchok JD; Livingston PO; Quinn C; Hwu WJ
    Melanoma Res; 2002 Aug; 12(4):381-7. PubMed ID: 12170188
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cyclosporine A, alpha-lnterferon and interleukin-2 following chemotherapy with BCNU, DTIC, cisplatin, and tamoxifen: a phase II study in advanced melanoma.
    Feun L; Marini A; Moffat F; Savaraj N; Hurley J; Mazumder A
    Cancer Invest; 2005; 23(1):3-8. PubMed ID: 15779861
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.